Drugs / DIDALA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05760456 | Mar 2023 → May 2024 | type 2 diabetes mellitus | Centre of Clinical Pharmacology, Hanoi Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DIDALA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05760456 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “DIDALA is a herbal medicine, produced from dried mulberry leaves.” NCT05760456 ↗ |
| Route | Oral | “DIDALA is given orally with a dose of 2 capsules, 3 times per day for 12 weeks” NCT05760456 ↗ |